Inovio Pharmaceuticals (INO) Shares Outstanding (2016 - 2025)
Inovio Pharmaceuticals (INO) has disclosed Shares Outstanding for 16 consecutive years, with $69.0 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding rose 91.13% to $69.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $69.0 million through Dec 2025, up 91.13% year-over-year, with the annual reading at $69.0 million for FY2025, 91.13% up from the prior year.
- Shares Outstanding hit $69.0 million in Q4 2025 for Inovio Pharmaceuticals, up from $53.6 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $268.1 million in Q2 2023 to a low of $9.0 in Q1 2021.
- Historically, Shares Outstanding has averaged $79.0 million across 5 years, with a median of $26.0 million in 2024.
- Biggest five-year swings in Shares Outstanding: soared 2978591033.33% in 2023 and later crashed 100.0% in 2024.
- Year by year, Shares Outstanding stood at $18.1 million in 2021, then increased by 16.43% to $21.1 million in 2022, then rose by 8.07% to $22.8 million in 2023, then skyrocketed by 58.38% to $36.1 million in 2024, then skyrocketed by 91.13% to $69.0 million in 2025.
- Business Quant data shows Shares Outstanding for INO at $69.0 million in Q4 2025, $53.6 million in Q3 2025, and $36.7 million in Q2 2025.